Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents a mixed picture. While there are positive indicators like strong SWU sales and a significant backlog, uncertainties remain around cost increases and management's vague responses during the Q&A. The capital raise and strategic partnerships are promising, but the lack of specific guidance and potential government inaction on import cutoffs could dampen enthusiasm. Without clear market cap data, it's challenging to predict strong price movements, leading to a neutral sentiment.
Total Revenue for 2025 $448.7 million, a $6.7 million or 1.5% increase over full year 2024. The increase was driven by a 21% increase in SWU revenue, offset by a 54% decrease in uranium revenue due to a large one-time uranium sale in Q4 2024.
LEU Segment Revenue for 2025 $346.2 million, relatively flat compared to $349.9 million in 2024. The flat performance was due to the offsetting effects of increased SWU revenue and decreased uranium revenue.
Uranium Revenue for 2025 $55.6 million, a 54% decrease year-over-year due to a large one-time uranium sale in Q4 2024.
SWU Revenue for 2025 Increased by 21% year-over-year or $51.9 million, driven by a 23% increase in the volume of SWUs sold.
Technical Solutions Segment Revenue for 2025 $102.5 million, an increase of $10.4 million or 11% over 2024 levels, driven by a $10.5 million increase in revenue from the HALEU operations contract.
Total Gross Profit for 2025 $117.5 million, a $6 million or roughly 5% increase over 2024 gross profit. This was driven by increased SWU sales volume and improved margins on SWU sales, partially offset by decreased uranium gross profit.
LEU Segment Gross Profit for 2025 $111.5 million, a $17.6 million or roughly 19% increase over 2024, driven by increased SWU sales volume and improved margins on SWU sales.
Technical Solutions Segment Gross Profit for 2025 $6 million, a decrease of $11.6 million or 66% year-over-year, due to increased costs under the HALEU operations contract and decreased costs related to other contracts.
Cost of Sales for LEU Segment in 2025 Decreased by $21.3 million or 8% to $234.7 million, driven by increased SWU sales volume and improved contract and pricing mix.
Cost of Sales for Technical Solutions Segment in 2025 Increased by $22 million or 30% to $96.5 million, driven by increased costs under the HALEU operations contract.
Net Income for 2025 $77.8 million, reasons for changes not explicitly mentioned.
Backlog as of December 31, 2025 $3.8 billion, with $2.9 billion in the LEU segment and $900 million in the Technical Solutions segment. The LEU backlog includes $2.3 billion in contingent LEU sale contracts.
Cash Balance at Year-End 2025 Approximately $2 billion, supported by $533.6 million raised through ATM programs and oversubscribed convertible senior note issuance.
Commercial centrifuge manufacturing: Centrus announced the start of commercial centrifuge manufacturing to address the commercial LEU market and backlog.
HALEU enrichment award: The Department of Energy selected Centrus for a $900 million HALEU enrichment award, potentially exceeding $1 billion.
LEU enrichment backlog: Centrus has a substantial commercial LEU enrichment backlog of $2.3 billion.
LEU market demand: Demand for LEU is increasing due to electrification needs, AI data centers, and Russia's market exit, with domestic demand set to rise by 6.5 million SWUs.
HALEU market: Centrus is positioned as a first mover in the global HALEU market, with plans to produce 12 metric tons of HALEU annually by the end of the decade.
National security market: Centrus is the only production-ready option for national security uranium enrichment, with potential sole-source contracts from the National Nuclear Security Administration.
Supply chain readiness: Centrus launched a supply chain readiness program in November 2024.
HALEU operations contract: Successfully delivered 900 kilograms of HALEU UF6 to the Department of Energy and produced over 1 metric ton of HALEU UF6 by the end of 2025.
Job creation: Created over 300 new jobs at the Piketon facility, with 140 employees added in 2025.
Facility design and renovation: Initiated design work on a training, operations, and maintenance facility in Piketon, including significant renovations.
Capital raising: Raised $533.6 million through ATM programs and ended 2025 with a $2 billion cash balance.
Partnerships: Signed an MOU with KHNP and POSCO International for potential foreign direct investment.
Operational guidance for 2026: Plans to finalize contracts with critical partners, add 150 net new employees, and release the first Certified for Construction work package in Piketon.
Supply Chain Disruptions: A scheduled shipment from Russia in Q4 2025 was delayed due to a shipping issue, pushing it to Q1 2026. This delay impacted gross margins and net income, highlighting potential vulnerabilities in the supply chain.
Regulatory and Contractual Risks: The HALEU operations contract remains undefinitized, and phase two costs incurred after November 2024 are not yet finalized. This creates uncertainty in cost recovery and financial planning.
Capital Deployment and Funding Risks: The company is embarking on a large-scale industrial build-out requiring significant capital deployment ($350M-$500M in 2026). While current funding appears sufficient, reliance on low-cost capital sources like government awards and foreign investments introduces potential risks if these sources do not materialize as expected.
Market Dependency and Competitive Pressures: The company is heavily reliant on the LEU and HALEU markets, which are subject to competitive pressures from state-backed competitors. The market also faces supply constraints, with demand expected to increase due to geopolitical factors like Russia's market exit.
Operational Execution Risks: The company is undertaking a complex build-out of centrifuge manufacturing and enrichment facilities, which involves significant design, construction, and workforce expansion. Delays or inefficiencies in these processes could impact timelines and costs.
Revenue Guidance for 2026: Total company revenue is projected to be between $425 million and $475 million, with the midpoint of $450 million representing flat year-over-year growth.
Capital Expenditures for 2026: Total capital deployment is expected to range from $350 million to $500 million, including prepaid expenses that impact free cash flow.
HALEU Production Timeline: HALEU production is planned to come online before the end of the decade, with an annual production capacity of 12 metric tons thereafter.
Workforce Expansion: At least 150 net new employees will be added across facilities in 2026, including 100 in Oak Ridge and 50 in Piketon, covering roles such as engineers, assembly technicians, and project managers.
Operational Milestones for 2026: Key milestones include finalizing contracts with critical partners, releasing the first Certified for Construction work package in Piketon, and completing the majority of construction partner mobilization in Ohio by year-end.
LEU Market Demand and Pricing: Domestic LEU demand is expected to increase by approximately 6.5 million SWUs due to factors like Russia's market exit and new reactor pledges. LEU pricing has shown a 24% CAGR from 2019 to 2025, indicating constrained supply and growing demand.
HALEU Enrichment Award: The $900 million HALEU enrichment award from the Department of Energy has the potential to exceed $1 billion, providing low-cost capital for capacity build-out.
Strategic Partnerships and Funding: Centrus is pursuing additional low-cost capital through national security-related funding, prepayment or offtake arrangements, and potential foreign direct investments.
The selected topic was not discussed during the call.
The earnings call presents a mixed picture. While there are positive indicators like strong SWU sales and a significant backlog, uncertainties remain around cost increases and management's vague responses during the Q&A. The capital raise and strategic partnerships are promising, but the lack of specific guidance and potential government inaction on import cutoffs could dampen enthusiasm. Without clear market cap data, it's challenging to predict strong price movements, leading to a neutral sentiment.
The earnings call summary reveals strong market growth and demand for nuclear fuel, driven by government and private investments. Centrus has secured significant backlog and future commitments, with strategic investments in readiness and manufacturing capabilities. The Q&A section indicates stable leasing spreads and positive rent growth potential. Despite some conservative tones and unclear management responses, the overall sentiment remains positive due to the company's strategic position and anticipated demand growth. The lack of available market cap data suggests a cautious but optimistic outlook for stock price movement.
The earnings call highlights Centrus' strong financial performance, strategic investments, and alignment with government initiatives, signaling optimism for future growth. Despite some management ambiguity in the Q&A, positive indicators like HALEU production milestones, an extended DOE contract, and a robust backlog outweigh concerns. The company's readiness for expansion and favorable market conditions further support a positive outlook.
The earnings call summary highlights strong financial performance with increased revenue and a significant backlog, indicating potential future growth. The Q&A section reveals ongoing strategic initiatives like centrifuge manufacturing and HALEU operations, which are progressing well. Although management was vague on some topics, the company's strong cash position and strategic public-private partnerships suggest a positive outlook. The lack of guidance on uranium sales and specific CapEx plans introduces some uncertainty, but overall, the financial health and strategic direction point towards a positive stock price movement in the short term.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.